Výsledky vyhledávání - "Arun Karunakaran"

Akademický článek

Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients

Autor: Ioanna Koniari, Eleni Artopoulou, Dimitrios Velissaris, Virginia Mplani, Maria Anastasopoulou, Nicholas Kounis, Cesare de Gregorio, Grigorios Tsigkas, Arun Karunakaran, Panagiotis Plotas, Ignatios Ikonomidis

Publikováno v: Medicina, Vol 58, Iss 6, p 743 (2022)

Atrial fibrillation (AF) and Heart failure (HF) constitute two frequently coexisting cardiovascular diseases, with a great volume of the scientific research referring to strategies and guidelines associated with the best management of patients suffer

Externí odkaz: https://doaj.org/article/8e3a16469c1247ba90ed78d8d820dc21

Zobrazit plný text záznamu

Evolving pattern of platelet P2Y12inhibition in patients with acute coronary syndromes

Autor: Clare Wales, Heather M Judge, Jemma Victoria Walker, Robert F. Storey, Rajiv R. Joshi, Allison Morton, Arun Karunakaran, Rosemary Ecob, Rashed Hossain

Publikováno v: Platelets. 25:416-422

Dual antiplatelet therapy consisting of clopidogrel in addition to aspirin has previously been the standard of care for patients with acute coronary syndromes (ACS) but international guidelines have been evolving over the last 4 years with the introd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e181255639e66678e87cf3c7380e892a
https://doi.org/10.3109/09537104.2013.836175

Zobrazit plný text záznamu

Success, Safety, and Efficacy of the Mynx Femoral Closure Device in a Real-World Cohort: Single-Center Experience

Autor: David Hutchings, Afzal Hayat, Arun Karunakaran, Nadim Malik

Publikováno v: University of Manchester-PURE

Femoral artery closure device use following percutaneous cannulation allows earlier mobilization, reduced staff burden, and improved comfort for patients compared with manual compression. The Mynx device (Access Closure, Inc), a novel extravascular c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4f266b2c9c8e8aae4878de8f8f8b3dc9
https://pubmed.ncbi.nlm.nih.gov/26945253

Zobrazit plný text záznamu

Contemporary Management of ST-Segment Elevation Myocardial Infarction

Autor: Julian Gunn, Arun Karunakaran, Wael Sumaya, Allison Morton, Robert F. Storey

Publikováno v: Hospital Practice. 40:224-231

Coronary heart disease is the leading cause of death worldwide. In the United States, approximately 1 of every 6 deaths in 2007 was caused by coronary heart disease. Clinical presentation in the acute setting is mostly due to atherosclerotic plaque r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6c3baff255d1ab66cbaeea146ba364
https://doi.org/10.3810/hp.2012.02.963

Zobrazit plný text záznamu

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

Autor: Shankar B. Patil, Arun Karunakaran, Gary Ledley, Tania Gesheff, Mark J. Antonino, Drew A. Purdy, Renli Teng, Cheryl Wei, Paul A. Gurbel, Vance Wilson, Dean J. Kereiakes, Udaya S. Tantry, Kevin P. Bliden, Kathleen Butler, Robert F. Storey, Cordel Parris

Publikováno v: Circulation. 120:2577-2585

Background— Ticagrelor is the first reversibly binding oral P2Y 12 receptor antagonist. This is the first study to compare the onset and offset of platelet inhibition (IPA) with ticagrelor using the PLATO (PLATelet inhibition and patient Outcomes)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::76f59d2daf74f0a334af887757da3661
https://doi.org/10.1161/circulationaha.109.912550

Zobrazit plný text záznamu

Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses

Autor: Cheryl Wei, Robert F. Storey, Rosemary Ecob, Kathleen Butler, Paul A. Gurbel, Kevin P. Bliden, Arun Karunakaran, U. S. Tantry

Publikováno v: Journal of thrombosis and haemostasis : JTH. 9(9)

The rate of recovery of platelet function after discontinuation of P2Y(12) inhibitors depends on the reversibility of the antiplatelet effect and the extent of the on-treatment response. P2Y(12) inhibition increases the bleeding risk in patients requ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f71c8891ceddc363f1bd3650b94931a4
https://pubmed.ncbi.nlm.nih.gov/21707911

Zobrazit plný text záznamu

Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study

Autor: Robert F, Storey, Kevin P, Bliden, Shankar B, Patil, Arun, Karunakaran, Rosemary, Ecob, Kathleen, Butler, Renli, Teng, Cheryl, Wei, Udaya S, Tantry, Paul A, Gurbel

Publikováno v: Journal of the American College of Cardiology. 56(3)

ObjectivesWe prospectively assessed cardiac and pulmonary function in patients with stable coronary artery disease (CAD) treated with ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET (A Multi-Centre Randomised, Double-Blind, Double-Dummy Paral

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf010027c28b1b7c29e76cc2d383ca8
https://pubmed.ncbi.nlm.nih.gov/20620737

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání